Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia
Authors:
- E. M. MortensenEME. M. Mortensen
- M. J. PughMPM. J. Pugh
- L. A. CopelandLCL. A. Copeland
- M. I. RestrepoMRM. I. Restrepo
- J. E. CornellJCJ. E. Cornell
- A. AnzuetoAAA. Anzueto
- J. A. PughJPJ. A. Pugh
- 24 October 2007
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 31 (3) , 611-617
Abstract
Recent studies suggest that statins and angiotensin-converting enzyme (ACE) inhibitors may have beneficial effects for some types of infections. The present study aimed to examine the association of outpatient use of these medications on 30-day mortality for subjects aged >65 yrs and hospitalised with community-acquired pneumonia.A retrospective national cohort study was conducted using the Department of Veterans Affairs administrative data including subjects aged ≥65 yrs hospitalised with community-acquired pneumonia, and having ≥1 yr of prior Veterans Affairs outpatient care.In total, 8,652 subjects were identified with a mean age of 75 yrs, 98.6% were male, and 9.9% of subjects died within 30 days of presentation. In this cohort, 18.1% of subjects were using statins and 33.9% were using ACE inhibitors. After adjusting for potential confounders, current statin use (odds ratio (OR) 0.54, 95% confidence interval (CI) 0.42–0.70) and ACE inhibitor use (OR 0.80, 95% CI 0.68–0.89) were significantly associated with decreased 30-day mortality.Use of statins and angiotensin-converting enzyme inhibitors prior to admission is associated with decreased mortality in subjects hospitalised with community-acquired pneumonia. Randomised controlled trials are needed to examine whether the use of these medications in patients hospitalised with community-acquired pneumonia may be beneficial.Keywords
This publication has 38 references indexed in Scilit:
- Trends in Hospitalizations for Pneumonia Among Persons Aged 65 Years or Older in the United States, 1988-2002JAMA, 2005
- The Effect of Statins on Mortality in Patients with BacteremiaClinical Infectious Diseases, 2001
- Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein LevelsCirculation, 2001
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001
- Anti-inflammatory treatment of acute and chronic pneumonia1Seminars in Respiratory Infections, 2001
- Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controlsThorax, 2000
- Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failureJACC, 1999
- Effect of statins on C-reactive protein in patients with coronary artery diseaseThe Lancet, 1999
- Patterns of Cytokine Expression in Community-Acquired PneumoniaChest, 1995
- Phagocyte function and cytokine production in community acquired pneumonia.Thorax, 1994